miR-129-2-3p mediates LPS-induced macrophage polarization and ferroptosis by targeting the SMAD3-GPX4 axis

Guixi Mo1, Jingna Guo2, Ligang Zhang3

  • 1Department of Anesthesiology, The First Affiliated Hospital, Jinan University, Guangzhou 510630, Guangdong, China.

Gene
|November 5, 2023
PubMed

Insights

MicroRNA-129-2-3p promotes macrophage ferroptosis and M1 polarization during sepsis by targeting SMAD3. This reveals a novel mechanism for sepsis therapy targeting macrophage dysfunction.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Macrophage dysfunction is central to sepsis progression, making them a key therapeutic target.
  • Targeting macrophage ferroptosis for sepsis treatment is gaining interest, but underlying mechanisms require elucidation.

Purpose of the Study:

  • To investigate the molecular mechanism of lipopolysaccharide (LPS)-induced macrophage ferroptosis and M1 polarization.
  • To identify the role of microRNA-129-2-3p (miR-129-2-3p) in regulating these processes.

Main Methods:

  • In vitro experiments using Mus musculus-derived macrophages.
  • Assays for apoptosis, glutathione (GSH), lipid peroxidation, GPX4, Arg-1, and iNOS levels.
  • Luciferase reporter assays to confirm gene targets.

Main Results:

  • LPS induced macrophage ferroptosis and up-regulated miR-129-2-3p.
  • miR-129-2-3p promoted LPS-induced M1 polarization and ferroptosis.
  • SMAD3 was identified as a direct target of miR-129-2-3p and negatively regulated by LPS.
  • SMAD3 inhibited LPS-induced M1 polarization and ferroptosis by targeting GPX4.

Conclusions:

  • miR-129-2-3p mediates LPS-induced macrophage M1 polarization and ferroptosis via the SMAD3-GPX4 axis.
  • This pathway offers a novel therapeutic strategy for sepsis targeting macrophage polarization and ferroptosis.